Zamanian Abbas, Farshchian Mehdi
Department of Dermatology, Sina Hospital, Hamedan University of Medical Sciences, Hamedan, Iran.
J Drugs Dermatol. 2007 Jul;6(7):703-6.
Immunosuppressive therapy is believed to be one of the most important risk factors in the development of skin cancer in renal transplant recipients.
Our purpose was to determine the types of neoplastic skin lesions encountered in Iranian renal transplant recipients and their associations with immunosuppressive regimens.
The entire bodies of renal transplant recipients attending an outpatient transplantation department were examined.
Neoplastic skin lesions were diagnosed in 13.1% of the renal transplant recipients. Actinic keratoses, squamous cell carcinomas, and basal cell carcinomas were the most common neoplastic skin lesions observed. Transplant recipients exposed to immunosuppressive therapy for more than 5 years have a significantly higher risk of developing skin cancers than recipients with less than 5 years of immunosuppressive therapy.
Our study confirmed the relatively high prevalence of neoplastic skin lesions among renal transplant recipients in the Iranian population.
免疫抑制疗法被认为是肾移植受者发生皮肤癌的最重要危险因素之一。
我们的目的是确定伊朗肾移植受者中出现的肿瘤性皮肤病变类型及其与免疫抑制方案的关联。
对在门诊移植科就诊的肾移植受者的全身进行检查。
13.1%的肾移植受者被诊断出患有肿瘤性皮肤病变。光化性角化病、鳞状细胞癌和基底细胞癌是观察到的最常见的肿瘤性皮肤病变。接受免疫抑制治疗超过5年的移植受者患皮肤癌的风险明显高于接受免疫抑制治疗少于5年的受者。
我们的研究证实了伊朗人群中肾移植受者肿瘤性皮肤病变的患病率相对较高。